BChE albumin fusions for the treatment of cocaine abuse

Details for Australian Patent Application No. 2010328305 (hide)

Owner Teva Pharmaceutical Industries Ltd.

Inventors Sklair-Tavron, Liora; Rosenstock, Moti; Shemesh-Darvish, Liron; Hallak, Hussein; Piryatinsky, Victor; Roschke, Viktor; Lafleur, David

Agent FB Rice

Pub. Number AU-A-2010328305

PCT Pub. Number WO2011/071926

Priority 61/283,791 08.12.09 US; 61/412,205 10.11.10 US

Filing date 7 December 2010

Wipo publication date 16 June 2011

International Classifications

A61K 38/16 Medicinal preparations containing peptides - Peptides having more than 20 amino acids

C12P 21/04 Preparation of peptides or proteins - Cyclic or bridged peptides or polypeptides, e.g. bacitracin

Event Publications

12 July 2012 PCT application entered the National Phase

  PCT publication WO2011/071926 Priority application(s): WO2011/071926

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010328310-RNA preparations comprising purified modified RNA for reprogramming cells

2010328303-Modular, scalable liquid management system